Barclays Maintains Underweight on Illumina, Raises Price Target to $365
Barclays analyst Peter Lawson maintains Illumina (NASDAQ:ILMN) with a Underweight and raises the price target from $355 to $365.
Illumina Q2 Earnings Boosted By Robust Growth In Core Sequencing Business; Uplifts FY21 Outlook
Illumina Inc (NASDAQ:ILMN) reported after the close of the market on Thursday that its second-quarter revenues grew 78% Y/Y to…
Illumina: Q2 Earnings Insights
Shares of Illumina (NASDAQ:ILMN) moved lower in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share were up 201.61% over the past year to $1.87, which beat the estimate of $1.35.
Illumina Q2 Adj. EPS $1.87 Beats $1.35 Estimate, Sales $1.13B Beat $1.01B Estimate
Illumina (NASDAQ:ILMN) reported quarterly earnings of $1.87 per share which beat the analyst consensus estimate of $1.35 by 38.52 percent. This is a 201.61 percent increase over earnings of $0.62 per share from the same
Earnings Scheduled For August 5, 2021
Companies Reporting Before The Bell
• OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.
Illumina-Grail $8B Merger Hit By European Commission’s In-Depth Investigation
The European Commission has opened an in-depth, three-month investigation into Illumina Inc’s (NASDAQ:ILMN) planned takeover of Grail, a deal valued between $7…
Tesla, Nio Significantly Cut From Baillie Gifford Portfolio, Here’s What The Firm Bought Instead In Q1
Investment management firm Baillie Gifford shed significant stake in electric carmakers Tesla Inc (NASDAQ: TSLA) and Nio Inc (NYSE: NIO) in the first quarter and bought shares in vaccine maker Moderna Inc